Wolverine Trading’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-100,200
| Closed | -$3.68M | – | 6182 |
|
|
2025
Q2 | $3.68M | Buy |
100,200
+1,300
| +1% | +$48.4K | ﹤0.01% | 1259 |
|
|
2025
Q1 | $3.94M | Sell |
98,900
-900
| -0.9% | -$30.3K | ﹤0.01% | 1118 |
|
|
2024
Q4 | $3.14M | Buy |
99,800
+45,200
| +83% | +$1.3M | ﹤0.01% | 1566 |
|
|
2024
Q3 | $1.3M | Sell |
54,600
-21,200
| -28% | -$463K | ﹤0.01% | 2091 |
|
|
2024
Q2 | $1.35M | Sell |
75,800
-3,100
| -4% | -$49.5K | ﹤0.01% | 1914 |
|
|
2024
Q1 | $1.2M | Buy |
78,900
+14,000
| +22% | +$223K | ﹤0.01% | 2040 |
|
|
2023
Q4 | $1.11M | Buy |
64,900
+9,000
| +16% | +$105K | ﹤0.01% | 2209 |
|
|
2023
Q3 | $467K | Sell |
55,900
-18,000
| -24% | -$251K | ﹤0.01% | 2836 |
|
|
2023
Q2 | $1.78M | Buy |
73,900
+42,400
| +135% | +$1.1M | ﹤0.01% | 1544 |
|
|
2023
Q1 | $461K | Buy |
+31,500
| New | +$478K | ﹤0.01% | 2588 |
|
|
2022
Q4 | – | Sell |
-21,400
| Closed | -$128K | – | 5027 |
|
|
2022
Q3 | $128K | Sell |
21,400
-9,900
| -32% | -$64.9K | ﹤0.01% | 3814 |
|
|
2022
Q2 | $135K | Sell |
31,300
-3,100
| -9% | -$19.4K | ﹤0.01% | 3720 |
|
|
2022
Q1 | $338K | Sell |
34,400
-17,900
| -34% | -$207K | ﹤0.01% | 3747 |
|
|
2021
Q4 | $1.01M | Sell |
52,300
-900
| -2% | -$23.4K | ﹤0.01% | 2605 |
|
|
2021
Q3 | $1.79M | Sell |
53,200
-100
| -0.2% | -$3.09K | ﹤0.01% | 2282 |
|
|
2021
Q2 | $2M | Buy |
53,300
+4,100
| +8% | +$161K | ﹤0.01% | 1977 |
|
|
2021
Q1 | $2.23M | Sell |
49,200
-44,800
| -48% | -$2.15M | ﹤0.01% | 1840 |
|
|
2020
Q4 | $4.97M | Buy |
94,000
+30,800
| +49% | +$1.04M | 0.01% | 1057 |
|
|
2020
Q3 | $1.65M | Sell |
63,200
-6,200
| -9% | -$143K | ﹤0.01% | 1623 |
|
|
2020
Q2 | $1.29M | Sell |
69,400
-21,100
| -23% | -$340K | ﹤0.01% | 1769 |
|
|
2020
Q1 | $934K | Sell |
90,500
-5,500
| -6% | -$69.5K | ﹤0.01% | 2004 |
|
|
2019
Q4 | $1.04M | Buy |
96,000
+4,400
| +5% | +$33.5K | ﹤0.01% | 2373 |
|
|
2019
Q3 | $518K | Buy |
91,600
+27,900
| +44% | +$195K | ﹤0.01% | 2592 |
|
|
2019
Q2 | $551K | Sell |
63,700
-6,700
| -10% | -$50.7K | ﹤0.01% | 2617 |
|
|
2019
Q1 | $566K | Sell |
70,400
-9,700
| -12% | -$52.4K | ﹤0.01% | 2629 |
|
|
2018
Q4 | $319K | Sell |
80,100
-57,500
| -42% | -$286K | ﹤0.01% | 3122 |
|
|
2018
Q3 | $771K | Buy |
137,600
+30,400
| +28% | +$347K | ﹤0.01% | 2626 |
|
|
2018
Q2 | $1.52M | Hold |
107,200
| – | – | ﹤0.01% | 1831 |
|
|
2018
Q1 | $1.52M | Buy |
+107,200
| New | +$1.37M | ﹤0.01% | 1831 |
|
|
2017
Q4 | – | Sell |
-69,900
| Closed | -$828K | – | 5476 |
|
|
2017
Q3 | $828K | Buy |
69,900
+12,000
| +21% | +$137K | ﹤0.01% | 2080 |
|
|
2017
Q2 | $614K | Sell |
57,900
-2,000
| -3% | -$22.4K | ﹤0.01% | 2232 |
|
|
2017
Q1 | $686K | Buy |
59,900
+42,600
| +246% | +$306K | ﹤0.01% | 2053 |
|
|
2016
Q4 | $80K | Buy |
+17,300
| New | +$101K | ﹤0.01% | 4116 |
|
Other funds holding TGTX
SCM
HRCM
Wolverine Trading's TGTX Position: Q2 2025 in Review
Wolverine Trading sold out of TG Therapeutics (TGTX) in Q2 2025, closing a stake of 6,120 shares — an estimated $228K sold.
Wolverine Trading first reported a position in TGTX in Q2 2016 and held it in 27 quarters. The position peaked at $4.56M in Q4 2020. 356 funds tracked by Wall St. Rank hold TGTX as of Q2 2025.
- Wolverine Trading reported no remaining TG Therapeutics position as of Q2 2025 after selling out during the quarter.
- Wolverine Trading sold 6,120 TG Therapeutics shares in Q2 2025, an estimated $228K.
- Wolverine Trading first reported a position in TG Therapeutics in Q2 2016 and held it in 27 quarters.
- Wolverine Trading's TG Therapeutics position peaked at $4.56M in Q4 2020.
- 356 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2025.
Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.